TXNM:NYSETXNM Energy, Inc. Analysis
Data as of 2026-05-28 - not real-time
$59.48
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
TXNM is trading just above its 20‑day SMA with a bullish MACD crossover and an RSI of 62, suggesting short‑term momentum, while the 30‑day volatility is low at under 3% and beta is near zero, indicating a very defensive price profile. The stock sits near its recent resistance of $59.53 and above the support at $58.67, and market sentiment is in the "Extreme Greed" zone, yet the forward PE of 18 contrasts sharply with a trailing PE of 42, far above the industry average, and the DCF fair‑value estimate is dramatically lower than the current price. Fundamentally, the company carries a massive debt‑to‑equity ratio above 160, a negative free cash flow, and a dividend payout ratio exceeding 100%, raising serious concerns about dividend sustainability.
Recent news highlights regulatory scrutiny over a $400 million stock sale to Blackstone and an $11.5 billion acquisition proposal, adding to the regulatory risk profile. The combination of overvalued multiples, high leverage, and questionable dividend coverage suggests limited upside despite the bullish technical setup, supporting a cautious stance for investors.
Recent news highlights regulatory scrutiny over a $400 million stock sale to Blackstone and an $11.5 billion acquisition proposal, adding to the regulatory risk profile. The combination of overvalued multiples, high leverage, and questionable dividend coverage suggests limited upside despite the bullish technical setup, supporting a cautious stance for investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators (MACD, RSI)
- Proximity to resistance and support levels
- High market sentiment but overvalued price
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Elevated debt load and negative free cash flow
- Unsustainable dividend payout
- Regulatory scrutiny of major transactions
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Persistent overvaluation relative to fundamentals
- Potential for earnings pressure from debt servicing
- Uncertain dividend continuity
Key Metrics & Analysis
Financial Health
Revenue Growth4.60%
Profit Margin6.68%
P/E Ratio42.2
ROE5.41%
ROA2.06%
Debt/Equity163.55
P/B Ratio1.9
Op. Cash Flow$596.4M
Free Cash Flow$-634117504
Industry P/E21.9
Technical Analysis
TrendBullish
RSI62.7
Support$58.67
Resistance$59.53
MA 20$59.28
MA 50$58.97
MA 200$58.19
MACDBullish
VolumeDecreasing
Fear & Greed Index91.5
Valuation
Fair Value$8.37
Target Price$60.79
Upside/Downside2.21%
GradeOvervalued
TypeGrowth
Dividend Yield2.84%
Risk Assessment
Beta0.06
Volatility2.88%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.